Self-Assembled Nano-Immunostimulant for Synergistic Immune Activation

Chembiochem. 2017 Sep 5;18(17):1721-1729. doi: 10.1002/cbic.201700246. Epub 2017 Jul 19.

Abstract

Immunotherapy has become one of the most promising therapies for the treatment of diseases. Synthetic immunostimulants and nanomaterial immunostimulant systems are indispensable for the activation of the immune system in cancer immunotherapy. Herein, a strategy for preparing self-assembled nano-immunostimulants (SANIs) for synergistic immune activation is reported. Three immunostimulants self-assemble into nanoparticles through electrostatic interactions. SANIs showed strong synergistic immunostimulation in macrophages. SANIs could also induce a strong antitumor immune response to inhibit tumor growth in mice and act as an efficient adjuvant of antitumor vaccines. Therefore, SANIs may be generally applied in cancer immunotherapy. This novel SANI strategy provides a new way for the development of both immunostimulants and -suppressants.

Keywords: antibodies; cancer; immunochemistry; nanoparticles; self-assembly.

MeSH terms

  • Adjuvants, Immunologic / chemistry
  • Adjuvants, Immunologic / metabolism*
  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use
  • Animals
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cytokines / metabolism
  • Dynamic Light Scattering
  • Female
  • Fluoresceins / chemistry
  • Immunotherapy
  • Lipopeptides / chemistry
  • Lipopeptides / immunology
  • Lipopeptides / pharmacology
  • Lipopeptides / therapeutic use
  • Macrophages / cytology
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Melanoma, Experimental / therapy
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Microscopy, Fluorescence
  • Nanoparticles / chemistry*
  • RAW 264.7 Cells
  • Toll-Like Receptor 2 / metabolism
  • Transplantation, Homologous
  • Vaccines, Synthetic / immunology

Substances

  • Adjuvants, Immunologic
  • Cytokines
  • Fluoresceins
  • Lipopeptides
  • Pam(3)CSK(4) peptide
  • Toll-Like Receptor 2
  • Vaccines, Synthetic
  • 6-carboxyfluorescein